ANDA 70301, held by Watson Laboratories. Hydrochlorothiazide; Propranolol Hydrochloride.
As of Nov 22, 2026, ANDA 70301 (Propranolol Hydrochloride and Hydrochlorothiazide), held by Watson Laboratories, was first approved by FDA on Apr 18, 1986, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 18, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Propranolol Hydrochloride and Hydrochlorothiazide25MG;40MG · tablet;oral | Hydrochlorothiazide; Propranolol Hydrochloride | Discontinued |
| Apr 28, 1998 | Supplement 12Labeling | Approved | None posted |
| Jan 31, 1997 | Supplement 11Manufacturing | Approved | None posted |
| May 1, 1991 | Supplement 10Labeling | Approved | None posted |
| Mar 21, 1991 | Supplement 9Labeling | Approved | None posted |
| Aug 2, 1988 | Supplement 8Manufacturing | Approved | None posted |
| Jan 13, 1988 | Supplement 7Manufacturing | Approved | None posted |
| Aug 7, 1987 | Supplement 5Manufacturing | Approved | None posted |
| Dec 24, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Oct 10, 1986 | Supplement 1Manufacturing | Approved | None posted |
| Apr 18, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters